Ramnik Xavier
Director · MoonLake Immunotherapeutics
Individual
- 2026
- Jun 18, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ramnik Xavier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- da Silva Jorge Santos - $8.73M in MLTX purchases and sales in the last 12 months
- Kristian Reich - $8.14M in MLTX purchases and sales in the last 12 months
- Matthias Bodenstedt - $3.20M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ramnik Xavier?
Ramnik Xavier is a corporate insider, tracked as Director of MoonLake Immunotherapeutics (MLTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ramnik Xavier last file a Form 4?
The only primary Form 4 on record is dated 18 June 2026.